相关实验视频

Updated: Jul 6, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

针对癌症治疗的PIM的全面见解:前景和障碍

Li Chen^1,2,3, Wuyu Mao¹, Changyu Ren⁴

¹Department of Neurology, Joint Research Institution of Altitude Health and Institute of Respiratory Health and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.

Journal of medicinal chemistry

|January 2, 2024

概括

预病毒整合部位 (PIM) 激酶调节细胞过程. 针对PIM的小分子抑制剂,如Uzanserti,正在进行针对癌症的临床试验,例如扩散大B细胞淋巴瘤.

科学领域:

生物化学生物化学
分子生物学分子生物学
在瘤学瘤学.

背景情况:

预病毒集成位点 (PIM) 激酶 (PIM-1,PIM-2,PIM-3) 是高度保守的氨酸/氨酸激酶.
皮姆基因酶通过酸化调节关键细胞功能,包括转录,翻译,增殖,亡和能量代谢.

研究的目的:

审查PIM激酶的结构和生物特征.
总结临床试验中PIM小分子抑制剂的研究进展.
评估挑战,并探索PIM抑制剂发现的近期药物化学努力.

主要方法:

关于PIM激酶研究的文献综述.
对PIM抑制剂正在进行的临床试验的分析.
探索用于小分子抑制剂设计的药物化学策略.

主要成果:

几种PIM抑制剂正在临床开发中,Uzanserti (5) 已经完成了针对复发性扩散大B细胞淋巴瘤的I期试验.
最近的进展集中在设计和发现针对PIM激酶的新型小分子抑制剂.

结论:

在瘤学中,PIM激酶是一个有前途的治疗点.
持续的药物化学努力对于克服挑战和推进临床应用的PIM抑制剂开发至关重要.

更多相关视频

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...